why choose us

First received: April 12, 2024

Clinical Trial: Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Corneal Erosion

Study Type: INTERVENTIONAL


Official Title: A Clinical Study on the Safety and Efficacy of SHJ002 Sterile Ophthalmic Solution in the Treatment of Corneal Erosion in Patients With Sjogren's Syndrome

Brief Summary: The purpose of this study is to measure efficacy and safety with 0.25% SHJ002 sterile ophthalmic solution compared to vehicle in treating corneal erosion in Sjogren's patients.SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.

Read more